Skip to main content
Fig. 2 | Virology Journal

Fig. 2

From: Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study

Fig. 2

Kaplan–Meier survival analysis of HBsAg response occurrence. a K-M survival analysis of HBsAg response rate between CHB + MASLD group and CHB group; b K-M survival analysis of the incidence of HBsAg response with different degrees of MASLD in the CHB + MASLD group; c K-M survival analysis of the incidence of HBeAg-negative HBsAg responses; d K-M survival analysis of the incidence of HBeAg-positive HBsAg responses

Back to article page